Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

PPM Secondary Transaction Trends

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Winter 2024

Private equity healthcare exit activity has declined the last two years, but in recent months there have been several milestone transactions bolstered by a new wave of PPM consolidators: pharma / drug distributors and multi-specialty acquirers. These two buyer cohorts provide more exit options for investor-backed MSOs and have added renewed confidence in the secondary market for specialty physician platforms.

Provident is pleased to share its observations as to why these two buyer cohorts are increasingly interested in specialty PPM platforms and how these transactions are being structured. For further questions or discussion, please reach out to Scott Davis (sdavis@providenthp.com), Eric Major (emajor@providenthp.com), or Kevin McDermott (kmcdermott@providenthp.com).

 

[holo_button icon=”/wp-content/uploads/2024/08/Provident-Healthcare-Partners-PPM-Secondary-Transaction-Trends_vFF.pdf” link=” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]